Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.

Nyman, Jackson; Denize, Thomas; Bakouny, Ziad; Labaki, Chris; Titchen, Breanna M; Bi, Kevin; Hari, Surya Narayanan; Rosenthal, Jacob et al. · Cell Rep Med · 2023

retrospective_cohort · Level III

Where this comes from

Abstract

Clear cell renal cell carcinoma (ccRCC) is molecularly heterogeneous, immune infiltrated, and selectively sensitive to immune checkpoint inhibition (ICI). However, the joint tumor-immune states that mediate ICI response remain elusive. We develop spatially aware deep-learning models of tumor and immune features to learn representations of ccRCC tumors using diagnostic whole-slide images (WSIs) in untreated and treated contexts (n = 1,102 patients). We identify patterns of grade heterogeneity in WSIs not achievable through human pathologist analysis, and these graph-based "microheterogeneity" structures associate with PBRM1 loss of function and with patient outcomes. Joint analysis of tumor phenotypes and immune infiltration identifies a subpopulation of highly infiltrated, microheterogeneous tumors responsive to ICI. In paired multiplex immunofluorescence images of ccRCC, microheterogeneity associates with greater PD1 activation in CD8<sup>+</sup> lymphocytes and increased tumor-immune interactions. Our work reveals spatially interacting tumor-immune structures underlying ccRCC biology that may also inform selective response to ICI.

Medical subject headings